MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Prevalence of Parkinson’s disease in the region of Coquimbo, Chile

M. Contreras, P. Pizarro, U. Hernandez, C. Gomez, J. Gajardo (La Serena, Chile)

Meeting: 2016 International Congress

Abstract Number: 485

Keywords: Parkinsonism

Session Information

Date: Monday, June 20, 2016

Session Title: Epidemiology

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To determine the rate of prevalence of PD in the region of Coquimbo, Chile.

Background: Parkinson’s disease is a common neurodegenerative disease, second after to Alzheimer’s disease, which affects approximately 1-2% of the population over 65, altering their quality of life.

Methods: Is a descriptive epidemiological study based on retrospective data from Regional records Explicit Health Guarantees (GES) and hospital medical records. All these measures were stratified by age, gender and geographical location. The total number of Parkinson’s cases was used to calculate the prevalence rates per 100,000 of the total population. Demographic data was extrapolated to 2015 using 2002 census.

Results: 581 people were registered with diagnosis of DP, establishing the prevalence rate of 76 per 100,000 inhabitants, ranging from 24-200 depending on the commune. The study population had an average age of 73 years (± 9.8), with 46% of women (p> 0.05). Were 496 people over 60 years, equivalent to 0.22% of the total population. With respect to the communities studied, the most prevalent was called Paihuano with a rate of 200 per 100,000 inhabitants. The capital of the region called La Serena, had a prevalence of 111 per 100,000 inhabitants. In over 60 years, a prevalence of 685 per 100,000 people over 60 years.

Conclusions: The figures resemble those found references in other countries but with somewhat lower rates which suggests that there is underdiagnosis or underreporting.

To cite this abstract in AMA style:

M. Contreras, P. Pizarro, U. Hernandez, C. Gomez, J. Gajardo. Prevalence of Parkinson’s disease in the region of Coquimbo, Chile [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/prevalence-of-parkinsons-disease-in-the-region-of-coquimbo-chile/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/prevalence-of-parkinsons-disease-in-the-region-of-coquimbo-chile/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley